Susquehanna Portfolio Strategies’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-280,217
Closed -$27.4M – 1013
2025
Q3
$27.4M Buy
+280,217
New +$29M 0.43% 52
2024
Q2
– Sell
-6,400
Closed -$438K – 548
2024
Q1
$438K Sell
6,400
-263,728
-98% -$17M 0.01% 612
2023
Q4
$15.6M Buy
+270,128
New +$14.4M 0.28% 102

Other funds holding BSX

Susquehanna Portfolio Strategies's BSX Position: Q4 2025 in Review

Susquehanna Portfolio Strategies sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 280,217 shares — an estimated $27.4M sold.

Susquehanna Portfolio Strategies first reported a position in BSX in Q4 2023 and held it in 3 quarters. The position peaked at $27.4M in Q3 2025. 1,795 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

  • Susquehanna Portfolio Strategies reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
  • Susquehanna Portfolio Strategies sold 280,217 Boston Scientific shares in Q4 2025, an estimated $27.4M.
  • Susquehanna Portfolio Strategies first reported a position in Boston Scientific in Q4 2023 and held it in 3 quarters.
  • Susquehanna Portfolio Strategies's Boston Scientific position peaked at $27.4M in Q3 2025.
  • 1,795 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Susquehanna Portfolio Strategies's 13F filing for Q4 2025, filed 17 Feb 2026.